Eisai, Bristol Myers Squibb enter collaboration for Eisai’s MORAb-202 antibody-drug conjugate EP News Bureau Jun 18, 2021 The companies are planning to move into the registrational stage of development for this asset as early as next year
Bristol-Myers Squibb Completes Acquisition of Celgene EP News Bureau Nov 21, 2019 Upon completion of the acquisition, pursuant to the terms of the merger agreement, Celgene became a wholly owned subsidiary of…
